<html>
<head>PUBMED IDs for SCA5</head>
<body bgcolor='#C5F0F2'><h1>SCA5</h1><a href='https://pubmed.ncbi.nlm.nih.gov/8838557/'>[Genetics of peripheral neuropathies and hereditary ataxias].</a> December 1  1995<br><a href='https://pubmed.ncbi.nlm.nih.gov/9109985/'>Clinical and molecular characteristics of a Brazilian family with spinocerebellar ataxia type 1.</a> September 1  1996<br><a href='https://pubmed.ncbi.nlm.nih.gov/9385362/'>Polymorphisms at 13 expressed human sequences containing CAG/CTG repeats and analysis in autosomal dominant cerebellar ataxia (ADCA) patients.</a> January 7  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/9613852/'>Analysis of SCA1, DRPLA, MJD, SCA2, and SCA6 CAG repeats in 48 Portuguese ataxia families.</a> June 5  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/9921902/'>A transcript map of an 800-kb region on human chromosome 11q13, part of the candidate region for SCA5 and BBS1.</a> January 28  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/9973298/'>Mapping of a new autosomal dominant spinocerebellar ataxia to chromosome 22.</a> February 11  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/10090679/'>Spinocerebellar ataxia 2 (SCA2): morphometric analyses in 11 autopsies.</a> March 25  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/10672773/'>[Autosomal dominant spinocerebellar ataxia].</a> February 15  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/12764052/'>A novel autosomal dominant spinocerebellar ataxia (SCA22) linked to chromosome 1p21-q23.</a> May 24  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14745083/'>Spinocerebellar ataxia type 5: clinical and molecular genetic features of a German kindred.</a> January 28  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/14998916/'>Dominantly inherited ataxia and dysphonia with dentate calcification: spinocerebellar ataxia type 20.</a> March 5  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15895561/'>Spinocerebellar ataxia type 20.</a> May 18  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16037936/'>Clinical feature profile of spinocerebellar ataxia type 1-8 predicts genetically defined subtypes.</a> July 23  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16927298/'>Spectrin mutations in spinocerebellar ataxia (SCA).</a> August 24  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17940722/'>Screening of the SPTBN2 (SCA5) gene in German SCA patients.</a> October 18  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/18418680/'>Clinical and genetic analysis of spinocerebellar ataxia type 11.</a> April 18  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19841386/'>Abraham Lincoln did not have type 5 spinocerebellar ataxia.</a> November 11  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19841380/'>Family history of melanoma and Parkinson disease risk.</a> November 11  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19841378/'>Novel susceptibility locus at chromosome 6q16.3-22.31 in a family with GEFS+.</a> November 11  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19841321/'>Phase II trial of pemetrexed plus bevacizumab for second-line therapy of patients with advanced non-small-cell lung cancer: NCCTG and SWOG study N0426.</a> February 19  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19841300/'>Genetic testing for long-QT syndrome: distinguishing pathogenic mutations from benign variants.</a> December 31  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19841298/'>Prevalence of the congenital long-QT syndrome.</a> December 31  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20030245/'>[Molecular genetic approach to spinocerebellar ataxias].</a> September 3  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20231455/'>Targeted deletion of betaIII spectrin impairs synaptogenesis and generates ataxic and seizure phenotypes.</a> April 29  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20368622/'>Spectrin mutations that cause spinocerebellar ataxia type 5 impair axonal transport and induce neurodegeneration in Drosophila.</a> June 24  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20371805/'>Loss of beta-III spectrin leads to Purkinje cell dysfunction recapitulating the behavior and neuropathology of spinocerebellar ataxia type 5 in humans.</a> April 27  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20437544/'>Sequencing analysis of the ITPR1 gene in a pure autosomal dominant spinocerebellar ataxia series.</a> July 29  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20723845/'>Autosomal dominant cerebellar ataxias: polyglutamine expansions and beyond.</a> September 14  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/22843192/'>A family with spinocerebellar ataxia type 5 found to have a novel missense mutation within a SPTBN2 spectrin repeat.</a> September 6  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23236289/'>Recessive mutations in SPTBN2 implicate β-III spectrin in both cognitive and motor development.</a> May 10  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23331413/'>Autosomal dominant cerebellar ataxia type III: a review of the phenotypic and genotypic characteristics.</a> July 24  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23331404/'>Clinical utility of the prostate cancer gene 3 (PCA3) urine assay in Japanese men undergoing prostate biopsy.</a> July 10  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23838597/'>Autosomal dominant SCA5 and autosomal recessive infantile SCA are allelic conditions resulting from SPTBN2 mutations.</a> January 21  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/25057192/'>Mutant β-III spectrin causes mGluR1α mislocalization and functional deficits in a mouse model of spinocerebellar ataxia type 5.</a> September 23  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25057185/'>Gene expression profiles induced by growth factors in in vitro cultured osteoblasts.</a> July 25  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25057181/'>CD226 (DNAM-1) is associated with susceptibility to juvenile idiopathic arthritis.</a> February 26  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25057173/'>EGFR biomarkers predict benefit from vandetanib in combination with docetaxel in a randomized phase III study of second-line treatment of patients with advanced non-small cell lung cancer.</a> June 13  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25057166/'>Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features.</a> June 13  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25142508/'>A Japanese SCA5 family with a novel three-nucleotide in-frame deletion mutation in the SPTBN2 gene: a clinical and genetic study.</a> July 3  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25142507/'>MicroRNA-155 attenuates activation of hepatic stellate cell by simultaneously preventing EMT process and ERK1 signalling pathway.</a> December 17  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/26883385/'>A human β-III-spectrin spinocerebellar ataxia type 5 mutation causes high-affinity F-actin binding.</a> December 27  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/28636205/'>Progressive SCAR14 with unclear speech, developmental delay, tremor, and behavioral problems caused by a homozygous deletion of the SPTBN2 pleckstrin homology domain.</a> June 22  2017<br></body></html>
